OFF-LABEL · NOT FDA-APPROVED
Melanotan 2 effects: what people report, and what the safety literature says
The reported upsides and downsides, kept clearly separate from the cited clinical and case-report findings.
The gist
Melanotan 2 effects fall into two columns, and this page keeps them apart. The first column is what users report: a fast, deep tan with little sun; a sharp drop in appetite; a surge in libido and spontaneous erections; and, on the downside, nausea, flushing, fatigue, and — most importantly — moles that darken or multiply.
The second column is what the published safety literature documents: case reports of serious harm, including kidney injury, prolonged painful erections, and melanoma in users. The reported effects below are anecdotal. The safety cautions below are cited.
None of this is medical advice and none of it includes a dose. If a mole changes during or after use, that is the one signal the case literature treats as urgent [16][17].
What people report
These are effects reported by the research-use community — anecdotal, not clinical evidence, and not verified by controlled trials. They are paraphrased from peptide-user forums and from published qualitative studies of those discussions [33][34]. No doses are attached.
Reported benefits.
- A rapid, deep tan with little or no sun. Very commonly cited as the main reason people seek it out — skin darkening within days, and a deeper color with far less sun or sunbed time than usual. This is consistently described as the whole point.
- Reduced appetite and weight loss. Very commonly reported, often from the first dose; many say they feel much less hungry within the first hour. People split on whether this is a welcome bonus or an off-putting effect.
- Increased libido and spontaneous erections (men). Commonly reported by men, often beginning with the first or second dose — a sudden surge in sex drive and unprompted erections, sometimes hours after injecting. Some welcome it; others find the spontaneous, hard-to-control erections uncomfortable. Women also report heightened arousal.
- Cosmetic satisfaction and confidence. Commonly reported as the reason for continuing — feeling more attractive and happier with their appearance. Some discussions note this can shade into preoccupation with looks.
Reported downsides.
- Nausea, sometimes vomiting. Very commonly reported, usually in the first hour after a dose and worst in the early days, often easing as use continues.
- Facial flushing and feeling hot. Commonly reported — the face going red and warm within minutes to an hour, usually short-lived.
- Darkening of existing moles and freckles. Very commonly reported, often the first visible sign anything is happening, with spots standing out more sharply than the surrounding skin.
- Appearance of new moles. A frequent and alarming report among longer-term users — new spots, sometimes many at once, sometimes within a day or two of a dose. This is often what prompts a doctor visit.
- Selective darkening of lips, gums, scars, and genital skin, which can look conspicuous; some report new facial patches resembling melasma.
- Fatigue and lethargy (users call it 'melanotan flu'), injection-site reactions, and a distinctive urge to stretch and yawn soon after a dose.
- An uneven, blotchy, or unnaturally long-lasting tan — patchy color, sometimes an orange or grey cast, that can linger for weeks to months and fade unevenly after stopping.
Melanotan 2 reddit and review threads
Discussions on forums and 'melanotan 2 reddit' threads track the published qualitative research closely: the tan is the draw, nausea and flushing are the early toll, and changing moles are the recurring worry [33][34]. A 2024 forensic study underscores why community 'melanotan 2 reviews' are an unreliable guide to what is in any given vial — products sold online vary widely in content and purity [22]. Treat all of it as reported experience, not evidence — and note that what a forum poster injected cannot be verified.
Is melanotan 2 safe? Safety and cautions
Melanotan 2 has no approved use and its long-term safety in humans is unknown [29][30]. The cautions below are grounded in the cited literature. Several are theoretical or based on single case reports — where that is so, it is stated.
New, changing, or darkening moles, and melanoma risk. Because Melanotan 2 drives melanocyte activity throughout the skin, case reports describe eruptive new moles, dysplastic (atypical) moles, and darkening of existing ones during use [16][17][18][19][20]. Separate case reports document melanoma and melanoma in situ in melanotan users [21][22], and dermoscopy studies show measurable change in moles during use [23]. The long-term melanoma risk is not established, but any new or changing mole during or after use warrants prompt dermatological assessment.
Rhabdomyolysis and acute kidney injury. A published case links a melanotan 2 injection to systemic toxicity with rhabdomyolysis — severe muscle breakdown [24]. A separate case report with literature review describes renal infarction most likely attributable to Melanotan 2, proposing both a thrombotic effect and possible direct kidney toxicity [4]. These point to potential for serious muscle and kidney injury; the mechanisms are not fully understood.
Priapism — a prolonged, painful erection. Because melanocortin agonism promotes erections, several case reports describe priapism after melanotan injections, including after apparent overdose [25][26][27]. Priapism is a urological emergency that can permanently damage erectile tissue if not treated quickly.
Posterior reversible encephalopathy syndrome (PRES). A case report describes PRES — a condition involving brain swelling that can cause headache, seizures, visual disturbance, and high blood pressure — in association with melanotan use [28]. This is consistent with the compound's reported effects on blood pressure.
Blood-pressure and cardiovascular effects. Preclinical work shows melanocortin agonists can raise blood pressure, an effect worsened in animals with impaired nitric oxide signaling [31][32]. Together with the very commonly reported nausea, this points to cardiovascular and gastrointestinal effects that are poorly characterized in humans using unregulated product.
Unregulated product — contamination, mislabeling, unknown content. Analyses of melanotan products bought online repeatedly find inaccurate labeling, variable or unverifiable peptide content, and impurities [22][35][36]. With no quality control, a buyer cannot know the true identity, dose, purity, or sterility of what is in the vial, which compounds every other risk.
Not the approved, distinct drugs. Melanotan 2 is sometimes confused with afamelanotide, an approved melanocortin therapy for the rare condition erythropoietic protoporphyria, and with the separately approved sexual-function melanocortin agonist developed from this peptide family [13][3]. Those approvals and their controlled-trial safety data do not extend to Melanotan 2, which is a different, unapproved compound used without medical oversight.
Melanotan 2 dangers and tanning, in context
The core 'melanotan 2 dangers' are the items above: changing moles against an unknown melanoma risk, the kidney and priapism case reports, and the gamble of unregulated product. Some users believe a deeper tan protects them from burning and treat 'melanotan 2 tanning' as a safety upside — but this is a user belief, not demonstrated protection, and many still report burning when they overdo sun exposure. Regulators including the FDA, the UK's MHRA, Australia's TGA, and Ireland's HPRA have specifically warned against melanotan tanning products [29][30].
Then and now
Melanotan 2 was designed in the late 1980s at the University of Arizona as a superpotent copy of alpha-MSH, intended to promote tanning and photoprotection and so perhaps reduce skin-cancer risk [14][3]. Early human work showed it could darken skin; researchers then noticed it triggered erections, which led to the small studies in men with erectile dysfunction and to the development of a spin-off agonist aimed at sexual dysfunction [3][13]. The original tanning program never reached the market. From the mid-2000s an illicit trade emerged, with the peptide sold online as unlicensed tanning injections — the so-called 'Barbie drug' — despite repeated regulator warnings [37][29]. It remains an unapproved research chemical with no sanctioned medical or cosmetic use [30].